IHS Chemical Week

EnviroTech :: Biotech

Actavis to Enter Biosimilars

8:37 AM MDT | September 8, 2010 | Deepti Ramesh

Generic pharmaceuticals producer Actavis (Hafnarfjordur, Iceland) says it plans to enter the field of biosimilars. Actavis has entered into an initial agreement with biotechnology company Bioton (Warsaw) to facilitate discussions for possibly entering into an agreement to acquire 51% stake in Biopartners (Baar, Switzerland), a unit of Bioton. Actavis will perform a due diligence of Biopartners. Financial terms have not yet been agreed. “By entering into biosimilars the generic companies gain access to a portfolio that requires a new approach to development...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa